Evaluation of HPV, smear and colposcopy results in patients with diabetes
| Autor: | Mehmet Ibrahim Harma, Sibel Balci, Anıl Turhan Çakir, Görker Sel, Muge Harma |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Endocrinology Diabetes and Metabolism Uterine Cervical Neoplasms Atypical Squamous Cells Alphapapillomavirus Cervical intraepithelial neoplasia Sensitivity and Specificity Pregnancy Internal medicine Diabetes mellitus Biopsy Internal Medicine medicine Diabetes Mellitus Humans In patient Papillomaviridae Early Detection of Cancer Retrospective Studies Colposcopy Vaginal Smears medicine.diagnostic_test business.industry Papillomavirus Infections virus diseases Hpv screening General Medicine medicine.disease DNA Viral Female business Ascus Papanicolaou Test |
| Zdroj: | Diabetesmetabolic syndrome. 16(1) |
| ISSN: | 1878-0334 |
| Popis: | Background and aims This study aimed to evaluate whether there is a difference in human papillomavirus (HPV), smear, and cervical biopsy results between patients with and without diabetes mellitus (DM). Methods Retrospectively, 136 patients with positive high risk (HR) HPV screening results with and without DM who underwent colposcopy between 2015 and 2019 were identified. The clinicopathological characteristics and HR HPV screening results were reported and analyzed. The results of the patients with and without DM were compared. Results HPV 16 positivity, Atypical Squamous Cells of Undetermined Significance (ASCUS), and Cervical Intraepithelial Neoplasia 1 (CIN 1) in smear and biopsy results were higher in patients with DM than patients without DM. Conclusions The higher HPV positivity in patients with diabetes may require reforming the frequency and method of cervical cancer screening to be applied to this patient group. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect